Cefprozil Powder For Oral Suspension 125Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Cefprozil: Powder for oral suspension (125mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png
Cefprozil 125mg/5ml for Susp
Drug Image file default-drug-image.png
Cefprozil 125mg/5ml for Susp
Drug Image file default-drug-image.png
Cefprozil 125mg/5ml for Susp

What is this Medicine?

CEFPROZIL (sef PROE zil) is a cephalosporin antibiotic. It is used to treat certain kinds of bacterial infections. It will not work for colds, flu, or other viral infections.

CVS Pharmacy Patient Statistics for Cefprozil: Powder for oral suspension(125mg)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information
Select a Medication

Cefprozil 125mg/5ml Powder for Suspension

NDC: 681800401
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Tonsillitis, Upper Respiratory Tract Infections, Skin And Skin Structure Infections, Pharyngitis, Sinusitis, Otitis Media, Lower Respiratory Tract Infections, Bronchitis

Storage Information
Store at controlled room temperature (between 68 and 77 degrees F)
Cefprozil 125mg/5ml Powder for Suspension

Reported Side Effects for Cefprozil 125mg/5ml Powder for Suspension

Confusion Incidence:
<0.1%*
Severity: MODERATE
Onset: EARLY
Anaphylactoid Reactions Incidence:
<1.0%*
Severity: SEVERE
Onset: RAPID
Kidney Inflammation Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Convulsions Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Yellow Skin Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Low Platelet Count Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Stevens-Johnson Syndrome Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Serum Sickness Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Pseudomembranous Colitis Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Inability To Sleep Incidence:
<0.1%*
Severity: MILD
Onset: EARLY
High Bilirubin Level Incidence:
<0.1%*
Severity: MODERATE
Onset: DELAYED
Headache Incidence:
<0.1%*
Severity: MILD
Onset: EARLY
Fever Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Erythema Multiforme Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Drowsiness Incidence:
<0.1%*
Severity: MILD
Onset: EARLY
Inflamed Colon Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Angioedema Incidence:
<1.0%*
Severity: SEVERE
Onset: RAPID
Hives Incidence:
0.1%*
Severity: MILD
Onset: RAPID
Low White Blood Cell Counts Incidence:
0.2%*
Severity: MODERATE
Onset: DELAYED
Elevated Hepatic Enzymes Incidence:
0.2-2.0%*
Severity: MODERATE
Onset: DELAYED
Skin Rash Incidence:
0.9%*
Severity: MILD
Onset: EARLY
Lightheadedness Incidence:
1.0%*
Severity: MILD
Onset: EARLY
Vomiting Incidence:
1.0%*
Severity: MILD
Onset: EARLY
Stomach Pain Incidence:
1.0%*
Severity: MILD
Onset: EARLY
Superinfection Incidence:
1.5%*
Severity: MODERATE
Onset: DELAYED
Vaginal Infection Incidence:
1.6%*
Severity: MODERATE
Onset: DELAYED
Itching Incidence:
1.6%*
Severity: MILD
Onset: RAPID
Eosinophilia Incidence:
2.3%*
Severity: MODERATE
Onset: DELAYED
Loose Stools Incidence:
2.9%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
3.5%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

SECOND Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

THIRD Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

Lactation

Compatible - This drug is generally safe to take by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Cefprozil

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5